Suresh Babu Naidu Krishna

PeerJ Author & Reviewer

Summary

Dr Suresh Krishna's primary research focus is on “nanoformulations and noncommunicable diseases.” Since his career began, he has optimized and developed scientific methods for rapid antimicrobial resistance and to better understand nanoparticle applications in biomedical science. His current projects in health sciences focus on non-communicable disease issues.
Dr Krishna has authored over 72 peer-reviewed publications, including groundbreaking papers in high-impact journals such as Journal of Materials Chemistry B, Frontiers in Microbiology, Materials Advances, Nanotechnology, Environmental Research, etc. He is co-PI in the SA UK Newton Fund Antibiotic Accelerator Initiative (2020-2025). Dr Krishna’s collaborations with international researchers have significantly advanced the field of nanotechnology. He holds a strong passion for providing research training and guidance to students and academics.

Agricultural Science Andrology Aquatic & Marine Chemistry Biochemistry Bioinspired materials Biomolecules Biosphere Interactions Biotechnology Catalysts Composites Coupled Natural & Human Systems Environmental Contamination & Remediation Gels Graphenes & Fullerenes Green Chemistry Microbiology Nano & Microstructured Materials Nanomaterials & Nanochemistry Natural Products Soil Science

Past or current institution affiliations

Durban Institute of Technology

University of Natal, Durban

Work details

Research Fellow

Durban Institute of Technology

January 2011

Biomedical and Clinical Technology

Current project is "Improving nanoparticle sensitivity for antimicrobial efficacy and augmented drug delivery using selected plant derived extracts and compounds". We employ a multi-prolonged approach by integrating cell, animal and clinical based studies to rapidly advance our hypothesis. Moreover, we aim to make significant impact at national and international levels-to be achieved by producing high impact research, fostering strong local and international collaborations and influencing awareness of medicinally important plants locally available. The focus will be two-fold- A). Elucidation of molecular mechanism of nanoparticles functionalized with antibacterial compounds is an interesting strategy to overcome the problem of multidrug resistance by bacteria B)Formulation of novel phytochemical based antimicrobial agents and we aim to identify new targets for therapeuticdrugs and vaccines. Research pedigree is evidenced by 10 conference presentations, 34 research articles in ISI-rated journals and my appointment to various strategic national and international committees within the higher education sector. I am presently actively involved in research projects involving Nanosciences, Plant biotechnology, Plant Renewable Energy and Probiotics, and co-supervise over 10 postgraduate students. Major projects completed 1.Antidiabetic and Antimicrobial Properties of Ocimum species (Ocimum basilicum and Ocimum sanctum) (L.) (March2012-Dec 2014) 2.Synthesis and antibacterial activity of silver and gold nanoparticles produced using aqueous seed extract of Protorhuslongifolia (2013-2014) 3.Expression and Partial Characterization of Saccharomyces cerevisiae cell wall related Mannoproteins (June 2012-2014,NRF Funded Project) 4.Genetic and Molecular studies on Bacillus sp. for potential probiotic applications (Jan 2011-June 2012)